Industry Leading Zero Chrom® Plasmid Manufacturing Platform — High Purity, Faster Production, & Cost Reduction
Expertise
- Extensive experience in process development and manufacturing, achieving a high success rate
- Industry-leading, unique Zero Chrom plasmid manufacturing platform offers low cost and minimal contamination risk.
- Industry-leading viral vector manufacturing platform delivers high yield, high purity products at lower cost per dose.
- Successfully served over 100 customers and delivered more than 400 batches.
Quality
- State-of-the-art facilities and a robust quality system ensure compliance with FDA, EMA, and NMPA standards
- Proven track record of IND approvals with the FDA and CDE
- Comprehensive QC testing aligned with the latest regulatory standards
Cost
- Cojourney’s innovative manufacturing processes deliver both cost and environmental benefits.
- Unique process and facility design minimize facility footprint, resulting in lower CAPEX, OPEX, and FTE costs.
- Cojourney leverages a robust supply chain network and established vendor relationships to prioritize both quality and cost-efficiency.
CMC Expertise to Accelerate Your Drug Development Journey
—Custom-Tailored to Your Therapeutic Program
Robust manufacturing solutions supported by regulatory and manufacturing expertise. Expediting the speed to market of your gene therapy product.
End-to-End Process Development and cGMP Manufacturing for Gene Therapy—Supporting Both Clinical and Commercial Applications with High Yields, High Purity, and Low Residuals
CoJourney helps gene therapy companies around the world develop and manufacture their products:
- Developing the process and manufacturing your product in GMP
- Developing analytical methods and test your product
- Performing releasing of your product for use
CoJourney is revolutionizing plasmid production with their Zero Chrom Plasmid Platform. This innovative technology:
- Creates high-purity plasmids for gene therapy
- Reduces costs significantly
- Makes production faster and eliminating cross-contamination risks
Robust, scalable platform manufacturing technology for the production of viral Vectors, and plasmids at costs
60-70%lower than competitors
Leading Plasmids and AAV manufacturing platform with a proven track record of securing
FDA and CDE INDapprovals
Plasmid manufacturing can scale up to
30L
Viral vector manufacturing can scale up to
500L
Established partnerships with
100+clients
CoJourney: A Remarkable CDMO Experience
- Simple, stage-gated contracts to mitigate risks for clients.
- Expert Quality Control: Extensive expertise in Analytical and QA ensures product quality.
- Continuous Process Improvement: Continued improvements to manufacturing processes and technology for enhanced quality, yield and lower cost.
- Quality Materials and Supply Chain: We work with reputable suppliers, and source GMP-grade raw materials for quality, availability, and cost.
News & Events
CoJourney Funding Propels US Expansion
CoJourney secures $30 million financing and announces expansion of US production operations.
Upcoming Events
Cell 2025, London, UK – Nov 11-12, 2025
Advanced Therapies USA 2025, Philadelphia, PA – November 18-19, 2025
Phacilitate – Advanced Therapies Week, San Diego, CA – Feb 9-12, 2026
Contact Us
Connect with our experts to discuss how CoJourney can help you in the development of innovative cell and gene therapies.
China Office:
Hangzhou CoJourney Bio Ltd. Bldg 15.
Hexiang Tech Center, Qiantang District,
Hangzhou City, Zhejiang Province
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
